CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled / 40 target
Drug / intervention
MAP Wound Matrix +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06600152
NCT06600152N/ACompletedOn Track (1.8/mo)Completion was 11mo ago
CompareCT.gov

A Randomized, Open-label, Investigational Safety Evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) Device as a Volumetric Biomaterial Scaffold Applied to Clean Wounds After Skin Cancer Surgery With Mohs Micrographic Surgery (MMS) Compared to Control.

Tempo Therapeutics·interventional·Posted Sep 19, 2024·Updated Jun 3, 2026

In Brief

A clinical study evaluating MAP Wound Matrix and DuoDerm for Wound Heal. Completed, enrolled 40 participants across 3 sites.

Detailed Summary

A randomized, open-label, investigational safety evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) device as a volumetric biomaterial scaffold applied to clean wounds after skin cancer surgery with Mohs micrographic surgery (MMS) compared to control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound Heal
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedSep 19, 2024
Enrollment StartAug 26, 2024
Primary CompletionJul 30, 2025
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 1.8 years ago

Arms & Interventions

Microporous Annealed Particle (MAP) Wound Matrixexperimental

The Microporous Annealed Particle (MAP) Wound Matrix device will be topically applied to the wound immediately following Mohs micrographic surgery (MMS).

Device: MAP Wound Matrix
Hydrocolloid dressing (DuoDerm)active_comparator

A hydrocolloid (DuoDerm) will be topically applied to the wound immediately following Mohs micrographic surgery.

Device: DuoDerm

Interventions

MAP Wound Matrixdevice

The MAP Wound Matrix is indicated for the management of full thickness wounds, including surgical sites, donor skin graft sites, wound dehiscence, lacerations, and draining wounds. The application of MAP Wound Matrix will occur immediately after Mohs surgery once hemostasis has been achieved

DuoDermdevice

DuoDerm is a hydrocolloid dressing will be topically applied to the wound immediately following Mohs surgery according to the manufacturer\'s instructions.